Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ-63576253 is a Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
2 mg | 在庫あり | ¥ 9,000 | |||
5 mg | 在庫あり | ¥ 15,000 | |||
10 mg | 在庫あり | ¥ 26,000 | |||
25 mg | 在庫あり | ¥ 57,000 | |||
50 mg | 在庫あり | ¥ 91,000 | |||
100 mg | 在庫あり | ¥ 135,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 17,500 |
説明 | JNJ-63576253 is a Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC). |
ターゲット&IC50 | Androgen receptor:37nM |
In vitro | JNJ-63576253 inhibits the growth of VCaP cells,with an IC50 of 265nM[1]. |
分子量 | 538.97 |
分子式 | C23H22ClF3N6O2S |
CAS No. | 2110428-64-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200mg/mL (371.08 mM)
H2O: insoluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JNJ-63576253 2110428-64-1 Endocrinology/Hormones Androgen Receptor TRC-253 JNJ63576253 mutant resistant wild-type TRC 253 JNJ 63576253 prostate inhibit castration cancer Inhibitor androgen CRPC LNCaP TRC253 inhibitor